1.1 Current Exam Facts & Format

What the DHA Pharmacist Licensing Assessment Is

The DHA Pharmacist Licensing Assessment is the licensing examination administered for Dubai Health (formerly the Dubai Health Authority, DHA) that every pharmacist must pass - or be exempted from - before being registered to practise in the Emirate of Dubai. Passing it does not by itself grant a licence; it establishes your eligibility, which an employer then converts into an active licence through the Sheryan professional licensing portal (covered in Section 1.2).

The exam is delivered as a computer-based test (CBT) through Prometric, under the exam code PHO5481, at Prometric test centres worldwide. The content is developed by subject-matter experts (SMEs) and reviewed against current scopes of practice, and the governing document is the official DHA Healthcare Professional Licensing Assessment Guideline (CBT), whose current published edition is headed Updated - July 2024. Always verify details against the current guideline before you book, because DHA revises it periodically.

Exam Facts at a Glance

A caution worth repeating: some third-party preparation websites still quote 120 questions for this exam. The official CBT Guideline lists 150 questions in 3 hours, and that is the figure you should plan around. Where any number in this chapter is not published in the official guideline, this guide says so rather than guessing.

How the Exam Is Scored

The pass mark is 60% - on a 150-question paper that equates to roughly 90 correct answers, although DHA does not publish an exact raw-cut-score table and you should treat 60% as the official threshold. Two scoring features shape your test-day tactics:

• No published negative-marking rule. The CBT Guideline sets out the format, duration and pass score but says nothing about deducting marks for wrong answers, so DHA publishes no penalty scheme. Since an unanswered item is certainly worth nothing while a reasoned elimination is not, the correct tactic either way is to leave no question blank.
• Pass/Fail reporting. Your result appears in your Sheryan account as Pass or Fail only. DHA does not share the numeric score, so you will not know whether you passed comfortably or narrowly - a good reason to prepare for a margin above the cut score rather than aiming at exactly 60%.

The 14 Official Content Areas

The official exam coverage is divided into 14 content areas, reproduced below as the CBT Guideline states them. One thing to be clear about before you plan: DHA publishes the area names only and does not publish a percentage weight for any of them. Preparation sites routinely quote weighted blueprints for this exam - you will find "Pharmacology 35%", "Clinical Pharmacy 30%", "Pharmaceutical Care 35%" and several other mutually contradictory tables - and none of them trace back to a DHA source. Plan from the area list itself, and treat the study-time allocation in Section 1.3 as this guide's reasoned estimate rather than an official figure.

Without official weights, read the list structurally instead. Four areas describe how a pharmacist reasons about a patient - clinical pharmacology and therapeutic decision making, pharmaceutical care and disease state management, pharmacokinetics, and over-the-counter medication - and applied clinical vignettes of exactly that kind dominate every published sample paper for this exam. Two more, pharmacy calculation and compounding and pharmacy law and ethics, test skills you can convert into near-certain marks by drilling. The remaining eight are narrower and largely factual. That ordering, not an invented percentage table, is what should drive your study plan.

Question Style and Time Pressure

Questions are single-best-answer MCQs: a stem - frequently a short clinical vignette - followed by four options, exactly one of which is correct. Many items are applied rather than recall-based: expect to choose the most appropriate pharmacist action, the correct dose or infusion rate, the drug most likely responsible for an adverse effect, or the legally required handling of a prescription. With ~72 seconds per question on average, you cannot afford to stall; calculation items will take longer than recall items, so banking time on straightforward pharmacology questions is part of the strategy developed in Section 1.3.

Attempt Limits and Why They Matter

The DHA Manual for Professional Assessment (version 1.1, effective 8 May 2025) sets the retake rules, and two of its clauses are commonly misreported:

• Three attempts. Clause 4.9 allows an applicant a total of three (3) attempts at the DHA assessment, under the published unified PQR. Clause 4.9.1 lets DHA cut that to one or two attempts if an assessment panel judges the competency gap serious enough to put patients at risk.
• No waiting period. Clause 4.8 states that an applicant with a fail result "may apply again to re-do the DHA assessment, no time restriction between assessment dates and according to assessment availability process." Many preparation sites quote a mandatory 90-day wait; DHA does not impose one. The practical delay is scheduling capacity at Prometric, not a policy cooling-off period.

What makes each sitting high-stakes is the ceiling, not a waiting period. Under clause 4.10, failing the third attempt blocks you from reapplying for a DHA licence for two years. Clause 4.11 allows one final attempt with a different UAE authority after three DHA failures, and a fourth DHA attempt only if you declare that you have not failed with any other UAE regulatory authority. Clause 4.12 restores a fresh set of three attempts if you obtain an additional recognised qualification under the PQR or acquire two years of licensed clinical experience after your last attempt. So sit only when timed mock performance is consistently above the pass mark; do not spend an attempt as a diagnostic. Retake planning is covered in Section 1.3.